MY ACCOUNT
Effects
Showing 1–12 of 364 results
Quetiapine for the Management of Tardive Dyskinesia in Schizoaffective Disorder Comorbid With Diabetes Mellitus and Chronic Kidney Disease
In this report, the authors describe the successful management of tardive dyskinesia with quetiapine in a man with schizoaffective disorder and comorbid diabetes with renal and neurologic complications as well as hypothyroidism and hypertension.
Visual Hallucinations After Treatment With Thiocolchicoside
This report presents a case in which a visually impaired patient describes the development of visual hallucinations after 2 oral administrations of thiocolchicoside.
Selecting Treatment for Patients With Tardive Dyskinesia Using Safety and Efficacy Evidence
Read an article on how to reduce Tardive dyskinesia (TD) symptoms, including the use of the FDA-approved treatment options (valbenazine and deutetrabenazine).
Bupropion: Delayed Allergic Reaction? | Psychiatrist.com
Read a case report on whether allergic reactions from bupropion is underrecognized due to patients receiving care from other physicians.
Psychiatric Side Effects of Chloroquine
Read a letter discussing psychiatric side effects that may arise with the use of Chloroquine.
Three Months of Treatment With Esketamine: Effects on Depression, Insomnia, and Weight
Management of resistant depression is challenging, as many patients have tried multiple medications and psychotherapy with no success. This report describes a case of resistant depression successfully treated with an intranasal form of ketamine.
A Serotonin "Cocktail"
Serotonin syndrome appears in different gradations of severity, affecting recognition and reporting. Read this case report to find out more about this condition.
Valproate and Neuroleptic Malignant Syndrome in an Elderly Patient With Schizoaffective Disorder
Neuroleptic malignant syndrome (NMS) is often associated with use of typical antipsychotics, but antiepileptics have also been implicated. This report describes the case of an elderly man with schizophrenia who experienced NMS with valproate.
Clozapine-Induced Enuresis: An Underrecognized and Undertreated Problem
New-onset enuresis may be an underreported side effect of clozapine. The authors of this case report recommend directly questioning patients about clozapine-induced enuresis rather than vaguely inquiring about side effects.
Prevalence and Associated Factors of Depression Among Diabetic Outpatients in Ethiopia
Depression has been associated with high mortality in people with diabetes. This study assessed the prevalence and associated factors of depression among diabetic outpatients in Ethiopia.
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland
Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in the general population.
Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial
How soon is too soon to look for metabolic syndrome in your patients with schizophrenia? This randomized open-label trial investigates 7 risk factors of 5 atypical and 2 typical antipsychotics to make recommendations for monitoring metabolic measurements.
